synthetic / sintéticas

Discussions فایل‌ها‌تصاویر Videos واصلیها Events Knowledge Share همه

Source: Di Trana, A., Berardinelli, D., Montanari, E., Berretta, P., Basile, G., Huestis, M. A., & Busardò, F. P. (2022). Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances. International Journal of Molecular Sciences, 23(23), 14619...

Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration New Trends and New Psychoactive Substances.pdf

Source: https://sin-adiccion.blogspot.com/2026/09/synthetic-drugs-drogas-sinteticas.html

Substances in this drug group, often referred to as designer drugs, are psychoactive compounds artificially manufactured in laboratory environments. Their potency and effects vary widely. Some synthetic drugs are designed to mimic stimulant activity, increasing brain activity, energy, and alertness. Others are engineered to produce hallucinogenic or psychedelic effects, leading to altered perceptions, vivid imagery, and changes in consciousness. Some function as depressants, slowing the central nervous...

Source: Carpenter, J., Murray, B. P., Atti, S., Moran, T. P., Yancey, A., & Morgan, B. (2020). Naloxone dosing after opioid overdose in the era of illicitly manufactured fentanyl. Journal of Medical Toxicology, 16(1), 41-48. https://doi.org/10.1007/s13181-019-00735-w Abstract Introduction Illicitly...

Click here → to read the full text

Centers for Disease Control and Prevention. (2025). Fentanyl. U.S. Department of Health and Human Services. Available at: https://www.cdc.gov/overdose-prevention/about/fentanyl.html Key points Fentanyl is a powerful synthetic opioid that can be used for surgery or to treat severe pain. The majority...

https://www.cdc.gov/overdose-prevention/about/fentanyl.html

Source: Khezri, M., Holm, J., Dahlen, A., Johnson, C., Agyabeng, K., Lei, F., Pagán, J. A., Healton, C., & Farhat, T. (2026). Illicit drug supply, naloxone availability, and overdose mortality in the fentanyl era: A systematic review. Health Affairs Scholar, 4(4), qxag074. https://doi.org/10.1093...

Illicit drug supply, naloxone availability, and overdose mortality in the fentanyl era a systematic review.pdf

Source: Albores-Garcia, D., & Cruz, S. L. (2023). Fentanyl and other New Psychoactive Synthetic Opioids. Challenges to Prevention and Treatment. Revista de Investigación ClíNica, 75(3), 93-104. https://doi.org/10.24875/RIC.23000109 ABSTRACT Synthetic opioids have played a significant role in the...

Fentanyl and other New Psychoactive Synthetic Opioids Challenges to Prevention and Treatment.pdf

Source: Sugarman OK, Marks C, Whitley P, Saloner B, German D. Xylazine-Fentanyl Positivity and Concentration in Urine Drug Tests. JAMA Netw Open. 2026;9(7):e2622473. doi:10.1001/jamanetworkopen.2026.22473 Key Points Question How are the presence and concentration of xylazine with fentanyl changing...

Xylazine-Fentanyl Positivity and Concentration in Urine Drug Tests.pdf

Source: Abukahok, N., Fitzgerald, N. D., & Palamar, J. J. (2025). An Update on the Epidemiology of Tusi ("Pink Cocaine"). Current addiction reports, 12, 90. https://doi.org/10.1007/s40429-025-00706-y Abstract Purpose of Review: Tusi, also known as “pink cocaine,” has emerged across nightlife scenes...

Click here → to read the full text

Este archivo PDF contiene el material de la presentación de Raúl Martín del Campo Sánchez para el webinario "Tuci: desafíos para la prevención y el tratamiento", del viernes 14 de agosto del 2026.

TUSI Raúl Martín del Campo Sánchez.pdf

Este archivo PDF contiene el material de la presentación de Juan Carlos Araneda Ferrer para el webinario "Tuci: desafíos para la prevención y el tratamiento", del viernes 14 de agosto del 2026.

TUCI Juan Carlos Araneda Ferrer 14 de agosto del 2026.pdf

Source: Vasquez-Rodriguez, J. F., Lemus-Barrios, G., Rangel-Rivera, D., Garnica-Sepulveda, V., Avila, Y., Medina-Mur, R., ... & Dueñas-Criado, K. (2026). TUSI Valve: Echocardiographic and Pathologic Correlates of a Novel Drug-Induced Valvular Disease—a Case Series. CASE. Highlights •TUSI ("pink...

TUSI Valve Echocardiographic and Pathologic Correlates of a Novel Drug-Induced Valvular Disease—a Case Series.pdf

Source: Fitzgerald, N. D., Abukahok, N., & Palamar, J. J. (2025). When pink powders shift the drug landscape: tusi ("pink cocaine") and other colored powders. The International journal on drug policy, 146, 105044. https://doi.org/10.1016/j.drugpo.2025.105044 Introduction “Tusi,” also known as...

Click here → to read the full text

Fuente: Ministerio de Salud y Protección Social, & Instituto Nacional de Salud. (2026, junio). Tusi, tusibí, cocaína rosada: Riesgos asociados al consumo de estas sustancias psicoactivas (Versión 1). Ministerio de Salud y Protección Social. El Ministerio de Salud y Protección Social (MSPS) y el...

tusi, tusibí, cocaína rosada Riesgos asociados al consumo de estas sustancias psicoactivas.pdf

Upcoming Events

There aren't any upcoming events

All Events

Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances

Synthetic Drugs

Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl

Fentanyl

Illicit drug supply, naloxone availability, and overdose mortality in the fentanyl era: a systematic review

Fentanyl and other New Psychoactive Synthetic Opioids. Challenges to Prevention and Treatment

Xylazine-Fentanyl Positivity and Concentration in Urine Drug Tests

An Update on the Epidemiology of Tusi (“Pink Cocaine”)

Tuci: desafíos para la prevención y el tratamiento presentación de Raúl Martín del Campo Sánchez

Tuci: desafíos para la prevención y el tratamiento presentación de Juan Carlos Araneda Ferrer

TUSI Valve: Echocardiographic and Pathologic Correlates of a Novel Drug-Induced Valvular Disease—a Case Series

When pink powders shift the drug landscape: tusi (“pink cocaine”) and other colored powders

Tusi, Tusibí, Cocaína rosada: riesgos asociados al consumo de estas sustancias psicoactivas

Upcoming Events